Patent · US Active

Combination adjuvant formulation

US9408908B2 · kind B2 · utility

2Cited by
16References
40Claims
0Family size

Inventors

Key dates

Filing dateFeb 15, 2013
Grant dateAug 9, 2016
Priority date
Expiry dateMar 27, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/18534
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions for enhancing an immune response to a selected antigen are described. The methods are useful for the treatment and prevention of microbial infections, such as infections caused by bacteria, viruses, fungi and parasites. The methods and compositions include host defense peptides, polyphosphazenes and immunostimulatory sequences to enhance the immune response to a coadministered antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.